SRX Global Inc. SRXH revenue by segment, product and geography
In its fiscal year ending 2025-09-30, SRX Global Inc. reported revenue across 1 business segments; the largest, Health Solutions, was $39.4M (-72.9% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Health Solutions$39.4Mshare n/a-72.9% yoy
member sum exceeds the consolidated figure: this axis carries more than one breakdown, so shares are not computed.
- United States$5.5M84.3%no prior
- Taiwan$833K12.7%no prior
- Other$196K3.0%no prior
Members sum to the consolidated $6.53M for this period.
- United States$2.94M85.3%no prior
- Asia$339K9.9%no prior
- Canada$165K4.8%no prior
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.